State of Wyoming’s Relay Therapeutics RLAY Stock Holding History

State of Wyoming’s Portfolio RLAY Stock Details RLAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-304	Closed	-$5K	–	1874
2022 Q2	$5K	Buy	+304	New	+$6.51K	﹤0.01%	1727

Other funds holding RLAY

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

State of Wyoming's RLAY Position: Q3 2022 in Review

State of Wyoming sold out of Relay Therapeutics (RLAY) in Q3 2022, closing a stake of 304 shares — an estimated $5K sold.

State of Wyoming first reported a position in RLAY in Q2 2022 and held it in 1 quarter. The position peaked at $5K in Q2 2022. 161 funds tracked by Wall St. Rank hold RLAY as of Q3 2022.

State of Wyoming reported no remaining Relay Therapeutics position as of Q3 2022 after selling out during the quarter.
State of Wyoming sold 304 Relay Therapeutics shares in Q3 2022, an estimated $5K.
State of Wyoming first reported a position in Relay Therapeutics in Q2 2022 and held it in 1 quarter.
State of Wyoming's Relay Therapeutics position peaked at $5K in Q2 2022.
161 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2022.

Based on State of Wyoming's 13F filing for Q3 2022, filed 14 Nov 2022.